Jihye Han Compares First-In-Class Drug Regulation in the US and Europe

Subscribe to UnitedHealthcare's Community & State newsletter.

Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on her recent paper that takes a closer look at the regulatory treatments for first-in-class drugs and how those differ between the US and Europe.

Order the March 2025 issue of Health Affairs.

Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.

Subscribe to UnitedHealthcare's Community & State newsletter.